Journal
LANGMUIR
Volume 32, Issue 17, Pages 4169-4178Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.langmuir.6b00511
Keywords
-
Funding
- Fond Quebecois de la Recherche sur la Nature et les Technologies (FRQNT) [PR-175718]
- Rotary International
Ask authors/readers for more resources
Controlled payload release is one of the key elements in the creation of a reliable drug delivery system. We report the discovery of a drug delivery vessel able to:transport chemotherapeutic agents to target cancer cells and selectively trigger their release using the electrochemical activity of a: ferrocene-modified phospholipid. Supported by in vitro assays, the competitive advantages of this discovery are (i) the simple one step scalability of the synthetic process, (ii) the stable encapsulation of toxic drugs (doxorubicin) during transport, and, (iii) the selective redox triggering of the liposomes to harness their cytotoxic payload at the cancer site. Specifically, the redox-modified giant unilamellar vesicle and liposomes were characterized using advanced methods such as scanning electrochemical microscopy (SECM), transmission electron microscopy (TEM), dynamic light scattering (DLS), and fluorescent imaging.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available